Some forms of this medicine (oxybutynin extended-release tablets) may not be for use in all ages of children
Eye pain; skin rash or hives You should not use oxybutynin if you are allergic to it, or if you have: 1
Oxybutynin is used to treat symptoms of an overactive bladder, such as incontinence (loss of bladder control) or a frequent need to urinate
Talk with the doctor
Oxybutynin is used to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability
13, 2021
This medication has been thoroughly researched and approved for use in patients aged 5 and older
Glaucoma: Use with caution in patients with treated angle-closure glaucoma; may exacerbate condition; use is contraindicated with uncontrolled narrow-angle
OXYBUTYNIN (ox i BYOO ti nin) treats symptoms of an overactive bladder, such as loss of bladder control or frequent need to urinate
Oxybutynin comes in short- and long-acting forms
While used for bed wetting in children, evidence to support this use is poor
This medication comes in tablet (immediate and extended release forms), gel, liquid (syrup) or transdermal (patch) form, and is taken up to 4 times daily, with or
Pediatric Use: Oxybutynin chloride extended-release tablets are not recommended in pediatric patients who cannot swallow the tablet whole without chewing, dividing or crushing, or in children under the age of 6 years
Oxybutynin should be swallowed whole with the help of liquids
Oxybutynin belongs to the group of medicines called antispasmodics
This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions
The recommended starting dose of DITROPAN XL® is 5 or 10 mg once daily at approximately the same time each day
A few noncomparative studies have shown promising results with oxybutynin ER in the treatment of adult and Oxybutynin ER Tablets 5 to 30 mg/day n=774 % Oxybutynin IR Tablets * 5 to 20 mg/day n The concomitant use of oxybutynin with other anticholinergic drugs or with other agents which produce dry mouth, constipation, somnolence (drowsiness), and/or other anticholinergic-like effects may increase the frequency and/or severity of such effects
Common Ditropan XL side effects may include: dizziness, drowsiness; headache; dry mouth; or
g
drowsiness (severe) fainting
Each DITROPAN XL® extended-release tablet contains 5 mg, 10 mg, or 15 mg of oxybutynin chloride USP, formulated as a once-a-day controlled-release tablet for oral administration